2025-01-14 |
Antibody-Drug Conjugates: Transforming the Biopharma Landscape |
2024-12-13 |
Trastuzumab: Transforming the Landscape of Breast Cancer Treatment |
2024-11-18 |
Rituximab: The First Monoclonal Antibody Approved for Cancer Treatment |
2024-11-11 |
How Antibodies are Used in Cancer Immunotherapy |
2024-10-08 |
Mechanisms of Action of Bispecific Antibodies in Cancer Therapy |
2024-10-08 |
Week 2, October 2024: ADCs in Regulatory Review |
2024-10-06 |
Antibody-Drug Conjugates and Immune Checkpoint Inhibitors in Cancer Treatment |
2024-10-04 |
September 2024: Bispecific Antibodies in Oncology |
2024-09-24 |
Week 4, September 2024: Anti-TIGIT Therapies |
2024-09-10 |
Week 2, September 2024: Non-Small Cell Lung Cancer |
2024-08-09 |
Transforming In Vivo Research with Bispecific Antibodies |
2024-07-30 |
Week 5, July 2024: ADCs & Gynecologic Cancer |
2024-07-26 |
Antibody-Mediated Phagocytosis Against Cancer |
2024-06-28 |
Immune Checkpoint Inhibitors and Antibody Therapeutics: A Paradigm Shift in Cancer Treatment |
2024-06-25 |
Week 4, June 2024: Immune Checkpoint Blockade |
2024-06-14 |
Multi-Payload Antibody–Drug Conjugates |
2024-06-04 |
Week 1, June 2024: Multi-Payload ADCs |
2024-05-28 |
Week 4, May 2024: Extensive-Stage Small-Cell Lung Cancer |
2024-05-24 |
Antibody Basics: Part 8 - Therapeutic targets - Oncology: What is cancer immunotherapy? |
2024-05-18 |
PEGS 2024 – Boston: Highlights and Event Recap |
2024-05-12 |
Chinese Antibody Society (CAS) Annual Conference 2024 – Boston: Event Recap |
2024-05-02 |
Innovating Cancer Treatment: Bispecific Antibody Drug Conjugates |
2024-04-17 |
AACR 2024 – San Diego: Summary and Research Highlights |
2024-04-16 |
Week 3, Apr 2024: Bispecific ADCs |
2024-04-11 |
Week 2, Apr 2024: Cancer Research Trends at AACR |
2024-03-29 |
Bispecific Antibodies: Design, Development, and Therapeutic Potential |
2024-03-12 |
Week 2, Mar 2024: The Battle Against Cancer |
2024-02-07 |
Week 1, Feb 2024: Challenging Multiple Myeloma |
2024-01-20 |
The Role of Antibodies in Immunotherapy |
2023-10-25 |
Antibody Therapeutics Against Cancer |